STAAR Surgical to Report Third Quarter Results on November 1, 2023
18 Outubro 2023 - 5:05PM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses for the eye, today
announced that it will release financial results for the third
quarter ended September 29, 2023 on Wednesday, November 1,
2023 after the market close.
STAAR will host a conference call and webcast on Wednesday,
November 1 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to
discuss its financial results and operational progress. To access
the conference call (Conference ID 03857916), please dial
888-259-6580 for domestic participants and 206-962-3782 for
international participants. The live webcast can be accessed from
the investor relations section of the STAAR website at
www.staar.com.
A taped replay of the conference call (Replay Code 857916) will
be available beginning approximately one hour after the call’s
conclusion for seven days. This replay can be accessed by dialing
877-674-7070 for domestic callers and 416-764-8692 for
international callers. An archived webcast will also be available
at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 40 years, designs, develops, manufactures and markets
implantable lenses for the eye. These lenses are intended to
provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are
foldable, which permits the surgeon to insert them through a small
incision. STAAR’s lens used in refractive surgery is called an
Implantable Collamer® Lens or “ICL”, which includes the EVO ICL™
product line. More than 2,500,000 ICLs have been sold to date and
STAAR markets these lenses in over 75 countries. To learn more
about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231018623693/en/
Investors & Media Brian Moore Vice President,
Investor, Media Relations and Corporate Development (626) 303-7902,
Ext. 3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024